211 related articles for article (PubMed ID: 16141403)
1. CD40 ligand influences platelet release of reactive oxygen intermediates.
Chakrabarti S; Varghese S; Vitseva O; Tanriverdi K; Freedman JE
Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2428-34. PubMed ID: 16141403
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil CD40 enhances platelet-mediated inflammation.
Vanichakarn P; Blair P; Wu C; Freedman JE; Chakrabarti S
Thromb Res; 2008; 122(3):346-58. PubMed ID: 18289643
[TBL] [Abstract][Full Text] [Related]
3. Platelet CD40L Modulates Thrombus Growth Via Phosphatidylinositol 3-Kinase β, and Not Via CD40 and IκB Kinase α.
Kuijpers MJ; Mattheij NJ; Cipolla L; van Geffen JP; Lawrence T; Donners MM; Boon L; Lievens D; Torti M; Noels H; Gerdes N; Cosemans JM; Lutgens E; Heemskerk JW
Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1374-81. PubMed ID: 25908768
[TBL] [Abstract][Full Text] [Related]
4. Soluble CD40 ligand impairs the anti-platelet function of peripheral blood angiogenic outgrowth cells via increased production of reactive oxygen species.
Bou Khzam L; Hachem A; Zaid Y; Boulahya R; Mourad W; Merhi Y
Thromb Haemost; 2013 May; 109(5):940-7. PubMed ID: 23426185
[TBL] [Abstract][Full Text] [Related]
5. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.
Santilli F; Davì G; Consoli A; Cipollone F; Mezzetti A; Falco A; Taraborelli T; Devangelio E; Ciabattoni G; Basili S; Patrono C
J Am Coll Cardiol; 2006 Jan; 47(2):391-7. PubMed ID: 16412866
[TBL] [Abstract][Full Text] [Related]
6. Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease.
Mason PJ; Chakrabarti S; Albers AA; Rex S; Vitseva O; Varghese S; Freedman JE
Am J Cardiol; 2005 Nov; 96(10):1365-9. PubMed ID: 16275179
[TBL] [Abstract][Full Text] [Related]
7. CD40-CD40 ligand mediates the recruitment of leukocytes and platelets in the inflamed murine colon.
Vowinkel T; Anthoni C; Wood KC; Stokes KY; Russell J; Gray L; Bharwani S; Senninger N; Alexander JS; Krieglstein CF; Grisham MB; Granger DN
Gastroenterology; 2007 Mar; 132(3):955-65. PubMed ID: 17324402
[TBL] [Abstract][Full Text] [Related]
8. The effect of dipyridamole on vascular cell-derived reactive oxygen species.
Chakrabarti S; Vitseva O; Iyu D; Varghese S; Freedman JE
J Pharmacol Exp Ther; 2005 Nov; 315(2):494-500. PubMed ID: 16046616
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers.
Graff J; Harder S; Wahl O; Scheuermann EH; Gossmann J
Clin Pharmacol Ther; 2005 Nov; 78(5):468-76. PubMed ID: 16321613
[TBL] [Abstract][Full Text] [Related]
10. The CD40-CD40L system in cardiovascular disease.
Pamukcu B; Lip GY; Snezhitskiy V; Shantsila E
Ann Med; 2011 Aug; 43(5):331-40. PubMed ID: 21244217
[TBL] [Abstract][Full Text] [Related]
11. Effects of alimentary lipemia and inflammation on platelet CD40-ligand.
Kälsch T; Elmas E; Nguyen XD; Kralev S; Leweling H; Klüter H; Dempfle CE; Borggrefe M
Thromb Res; 2007; 120(5):703-8. PubMed ID: 17289125
[TBL] [Abstract][Full Text] [Related]
12. Amyloid beta peptide-activated signal pathways in human platelets.
Shen MY; Hsiao G; Fong TH; Chen HM; Chou DS; Lin CH; Sheu JR; Hsu CY
Eur J Pharmacol; 2008 Jul; 588(2-3):259-66. PubMed ID: 18511035
[TBL] [Abstract][Full Text] [Related]
13. Enhanced levels of soluble CD40 ligand exacerbate platelet aggregation and thrombus formation through a CD40-dependent tumor necrosis factor receptor-associated factor-2/Rac1/p38 mitogen-activated protein kinase signaling pathway.
Yacoub D; Hachem A; Théorêt JF; Gillis MA; Mourad W; Merhi Y
Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2424-33. PubMed ID: 21071692
[TBL] [Abstract][Full Text] [Related]
14. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C
Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169
[TBL] [Abstract][Full Text] [Related]
15. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
16. The effects of tamoxifen and its metabolites on platelet function and release of reactive oxygen intermediates.
Vitseva O; Flockhart DA; Jin Y; Varghese S; Freedman JE
J Pharmacol Exp Ther; 2005 Mar; 312(3):1144-50. PubMed ID: 15509721
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase 9 is involved in Crohn's disease-associated platelet hyperactivation through the release of soluble CD40 ligand.
Menchén L; Marín-Jiménez I; Arias-Salgado EG; Fontela T; Hernández-Sampelayo P; Rodríguez MC; Butta NV
Gut; 2009 Jul; 58(7):920-8. PubMed ID: 19039088
[TBL] [Abstract][Full Text] [Related]
18. The CD40/CD40 ligand system: linking inflammation with atherothrombosis.
Antoniades C; Bakogiannis C; Tousoulis D; Antonopoulos AS; Stefanadis C
J Am Coll Cardiol; 2009 Aug; 54(8):669-77. PubMed ID: 19679244
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin diminishes platelet aggregation and sCD40L release. Potential role in the metabolic syndrome.
Restituto P; Colina I; Varo JJ; Varo N
Am J Physiol Endocrinol Metab; 2010 May; 298(5):E1072-7. PubMed ID: 20197504
[TBL] [Abstract][Full Text] [Related]
20. The inflammatory chemokine CXC motif ligand 16 triggers platelet activation and adhesion via CXC motif receptor 6-dependent phosphatidylinositide 3-kinase/Akt signaling.
Borst O; Münzer P; Gatidis S; Schmidt EM; Schönberger T; Schmid E; Towhid ST; Stellos K; Seizer P; May AE; Lang F; Gawaz M
Circ Res; 2012 Oct; 111(10):1297-307. PubMed ID: 22927331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
